The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2016

Filed:

Oct. 18, 2011
Applicants:

Alain D. Baron, San Diego, CA (US);

Martin R. Brown, Coronado, CA (US);

Christopher R. G. Jones, San Diego, CA (US);

Mark S. Fineman, San Diego, CA (US);

Inventors:

Alain D. Baron, San Diego, CA (US);

Martin R. Brown, Coronado, CA (US);

Christopher R. G. Jones, San Diego, CA (US);

Mark S. Fineman, San Diego, CA (US);

Assignee:

AMBRA BIOSCIENCE LLC, San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/28 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01); A61K 31/7016 (2006.01); A61K 31/155 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/216 (2006.01); A61K 31/353 (2006.01); A61K 31/4709 (2006.01); A61K 31/575 (2006.01); A61K 31/7032 (2006.01); A61K 31/704 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7016 (2013.01); A61K 31/155 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/353 (2013.01); A61K 31/4709 (2013.01); A61K 31/575 (2013.01); A61K 31/704 (2013.01); A61K 31/7032 (2013.01); A61K 45/06 (2013.01);
Abstract

Provided herein are methods of modulating hormone concentrations in a subject comprising the administration of a composition comprising a chemosensory receptor ligand, wherein the composition is adapted to deliver the ligand to one or more regions of the intestine of said subject. Also provided are methods directed to the modulation of circulating concentrations of one or more of GLP-1 (total), GLP-1 (active), GLP-2, oxyntomodulin, PYY (total), PYY 3-36, CCK, GIP, insulin, C-peptide, glycentin, uroguanylin amylin, and ghrelin (total), ghrelin (active) and glucagon.


Find Patent Forward Citations

Loading…